search icon
      blog search icon

      NBIX Stock Price History and Quote Analysis: Insights for Investors

      Neurocrine Biosciences, Inc.



      -0.18 (-0.16%)

      At Close: 4:00 PM

      NBIX Stock Price Graph

      • 1D
      • 5D
      • 1M
      • 3M
      • 6M
      • 1Y
      • YTD
      • All

      NBIX Stock Price Today

      Neurocrine Biosciences, Inc. (NBIX) stock rallied over 0.60% intraday to trade at $112.84 a share on NASDAQ. The stock opened with a loss of -5.11% at $107.25 and touched an intraday high of $108.28, falling -0.16% against the last close of $113.02. The Neurocrine Biosciences, Inc. in stock market went to a low of $106.01 during the session.

      NBIX Stock Snapshot


      Prev. Close

      11.09 Billion

      Market Cap


      Day Low




      Number of Shares


      Day High


      P/E ratio


      EPS (TTM)


      Cash Flow per Share


      Free Float in %


      Book Value



      NBIX Stock Price History Chart


      Contact Details

      12780 El Camino Real
      San Diego, CA 92130


      Contact #:858 617 7600

      Company Information



      Sales or Revenue$1.78 Billion

      5Y Sales Change65.25%

      Fiscal Year EndsDec. 2022


      IndustryDrug Manufacturers—Specialty & Generic

      About Company

      Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, a VMAT2 inhibitor for the treatment of tardive dyskinesia. The company's commercial products include ONGENTYS, a catechol-O-methyltransferase inhibitor used as an adjunct therapy to levodopa/DOPA decarboxylase inhibitors for patients with Parkinson's disease; ORILISSA for the management of moderate to severe endometriosis pain in women; and ORIAHNN, a non-surgical oral medication option for the management of heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. Its product candidates in clinical development include NBI-921352 for treating pediatric patients, as well as adult focal epilepsy indications; and NBI-827104 to treat rare pediatric epilepsy and essential tremor. The company's products in clinical development also comprise NBI-1065845 for the treatment of major depressive disorder; NBI-1065846 for treating anhedonia in major depressive disorder; and NBI-118568 for the treatment of schizophrenia. It has license and collaboration agreements with Heptares Therapeutics Limited; Takeda Pharmaceutical Company Limited; Idorsia Pharmaceuticals Ltd; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; BIAL – Portela & Ca, S.A.; Mitsubishi Tanabe Pharma Corporation; and AbbVie Inc. Neurocrine Biosciences, Inc. was incorporated in 1992 and is headquartered in San Diego, California.


      Frequently Asked Questions


      What is the current Neurocrine Biosciences, Inc. (NBIX) stock price?

      Neurocrine Biosciences, Inc. (NASDAQ: NBIX) stock price is $112.84 in the last trading session. During the trading session, NBIX stock reached the peak price of $108.28 while $106.01 was the lowest point it dropped to. The percentage change in NBIX stock occurred in the recent session was 0.60% while the dollar amount for the price change in NBIX stock was $0.67.


      NBIX's industry and sector of operation?

      The NASDAQ listed NBIX is part of Drug Manufacturers—Specialty & Generic industry that operates in the broader Healthcare sector. Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders.


      Who are the executives of NBIX?

      Dr. Kevin C. Gorman Ph.D.
      Chief Executive Officer & Director
      Mr. Darin M. Lippoldt Esq.
      Chief Legal Officer & Corporation Sec.
      Dr. Dimitri E. Grigoriadis
      Chief Research Officer
      Mr. David Warren Boyer
      Chief Corporation Affairs Officer


      How NBIX did perform over past 52-week?

      NBIX's closing price is 0.27% higher than its 52-week low of $89.04 where as its distance from 52-week high of $129.29 is -0.26%.


      How many employees does NBIX have?

      Number of NBIX employees currently stands at N/A. NBIX operates from 12780 El Camino Real, San Diego, CA 92130, US.


      Link for NBIX official website?

      Official Website of NBIX is:


      How do I contact NBIX?

      NBIX could be contacted at phone #858 617 7600 and can also be accessed through its website. NBIX operates from 12780 El Camino Real, San Diego, CA 92130, US.


      How many shares of NBIX are traded daily?

      NBIX stock volume for the day was 618541.00 shares. The average number of NBIX shares traded daily for last 3 months was 670.05 Thousands.


      What is the market cap of NBIX currently?

      The market value of NBIX currently stands at $11.09 Billion with its latest stock price at $112.84 and N/A of its shares outstanding.